Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

NCT04010305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Agitation
Schizophrenia

Interventions

DRUG: Sublingual film containing BXCL501 (Dexmedetomidine)
DRUG: Placebo film

Sponsor

BioXcel Therapeutics Inc

Collaborators

[object Object]